Aiding and abetting cancer: MRNA export and the nuclear pore

Trends in Cell Biology

Volumn 23, Issue 7, 2013, Pages 328-335

  Culjkovic Kraljacic, Biljana ^a   Borden, Katherine L B ^a  

^a INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; RIBOSOME RNA; SMALL NUCLEAR RNA;

CANCER SURVIVAL; CARCINOGENESIS; CELL PROLIFERATION; CHROMOSOME TRANSLOCATION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; HUMAN; MOLECULAR GENETICS; MRNA EXPORT; NEOPLASM; NONHUMAN; NUCLEAR EXPORT SIGNAL; NUCLEAR PORE; NUCLEAR PORE COMPLEX; PRIORITY JOURNAL; REVIEW;

ACTIVE TRANSPORT, CELL NUCLEUS; CELL NUCLEUS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MODELS, GENETIC; NEOPLASMS; NUCLEAR PORE COMPLEX PROTEINS; RNA TRANSPORT; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 84879602100     PISSN: 09628924     EISSN: 18793088     Source Type: Journal    
DOI: 10.1016/j.tcb.2013.03.004     Document Type: Review

References (89)

1. Strambio-De-Castillia C., et al. The nuclear pore complex: bridging nuclear transport and gene regulation. Nat. Rev. Mol. Cell Biol. 2010, 11:490-501.
2. Capelson M., Hetzer M.W. The role of nuclear pores in gene regulation, development and disease. EMBO Rep. 2009, 10:697-705.
3. Siddiqui N., Borden K.L. mRNA export and cancer. Wiley Interdiscip. Rev. RNA 2011, 3:13-25.
4. Kohler A., Hurt E. Gene regulation by nucleoporins and links to cancer. Mol. Cell 2010, 38:6-15.
5. Keene J.D. Minireview: global regulation and dynamics of ribonucleic acid. Endocrinology 2010, 151:1391-1397.
6. Mansfield K.D., Keene J.D. The ribonome: a dominant force in co-ordinating gene expression. Biol. Cell 2009, 101:169-181.
7. Speese S.D., et al. Nuclear envelope budding enables large ribonucleoprotein particle export during synaptic Wnt signaling. Cell 2012, 149:832-846.
8. Walde S., Kehlenbach R.H. The part and the whole: functions of nucleoporins in nucleocytoplasmic transport. Trends Cell Biol. 2010, 20:461-469.
9. Carmody S.R., Wente S.R. mRNA nuclear export at a glance. J. Cell Sci. 2009, 122:1933-1937.
10. Wente S.R., Rout M.P. The nuclear pore complex and nuclear transport. Cold Spring Harb. Perspect. Biol. 2010, 2:a000562.
11. Hutten S., Kehlenbach R.H. CRM1-mediated nuclear export: to the pore and beyond. Trends Cell Biol. 2007, 17:193-201.
12. Chatel G., Fahrenkrog B. Nucleoporins: leaving the nuclear pore complex for a successful mitosis. Cell. Signal. 2011, 23:1555-1562.
13. Bermejo R., et al. Preserving the genome by regulating chromatin association with the nuclear envelope. Trends Cell Biol. 2012, 22:465-473.
14. Hou C., Corces V.G. Nups take leave of the nuclear envelope to regulate transcription. Cell 2010, 140:306-308.
15. Kohler A., Hurt E. Exporting RNA from the nucleus to the cytoplasm. Nat. Rev. Mol. Cell Biol. 2007, 8:761-773.
16. Rodriguez-Navarro S., Hurt E. Linking gene regulation to mRNA production and export. Curr. Opin. Cell Biol. 2011, 23:302-309.
17. Luna R., et al. New clues to understand the role of THO and other functionally related factors in mRNP biogenesis. Biochim. Biophys. Acta 2012, 1819:514-520.
18. Katahira J. mRNA export and the TREX complex. Biochim. Biophys. Acta 2012, 1819:507-513.
19. Ren Y., et al. Structural and functional analysis of the interaction between the nucleoporin Nup98 and the mRNA export factor Rae1. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:10406-10411.
20. Fontoura B.M., et al. The nucleoporin Nup98 associates with the intranuclear filamentous protein network of TPR. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:3208-3213.
21. Bernad R., et al. Nup358/RanBP2 attaches to the nuclear pore complex via association with Nup88 and Nup214/CAN and plays a supporting role in CRM1-mediated nuclear protein export. Mol. Cell. Biol. 2004, 24:2373-2384.
22. Hamada M., et al. Ran-dependent docking of importin-beta to RanBP2/Nup358 filaments is essential for protein import and cell viability. J. Cell Biol. 2011, 194:597-612.
23. Dawlaty M.M., et al. Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. Cell 2008, 133:103-115.
24. Folkmann A.W., et al. Dbp5, Gle1-IP6 and Nup159: a working model for mRNP export. Nucleus 2011, 2:540-548.
25. Huang Y., Steitz J.A. SRprises along a messenger's journey. Mol. Cell 2005, 17:613-615.
26. Long J.C., Caceres J.F. The SR protein family of splicing factors: master regulators of gene expression. Biochem. J. 2009, 417:15-27.
27. Nguyen K.T., et al. The CRM1 nuclear export protein in normal development and disease. Int. J. Biochem. Mol. Biol. 2012, 3:137-151.
28. Dong X., et al. Structural basis for leucine-rich nuclear export signal recognition by CRM1. Nature 2009, 458:1136-1141.
29. Hutten S., Kehlenbach R.H. Nup214 is required for CRM1-dependent nuclear protein export in vivo. Mol. Cell. Biol. 2006, 26:6772-6785.
30. Walther T.C., et al. The cytoplasmic filaments of the nuclear pore complex are dispensable for selective nuclear protein import. J. Cell Biol. 2002, 158:63-77.
31. Brennan C.M., et al. Protein ligands to HuR modulate its interaction with target mRNAs in vivo. J. Cell Biol. 2000, 151:1-14.
32. Kimura T., et al. CRM1-dependent, but not ARE-mediated, nuclear export of IFN-alpha1 mRNA. J. Cell Sci. 2004, 117:2259-2270.
33. Saito K., et al. TAP/NXF1, the primary mRNA export receptor, specifically interacts with a neuronal RNA-binding protein HuD. Biochem. Biophys. Res. Commun. 2004, 321:291-297.
34. Yang J., et al. Two closely related human nuclear export factors utilize entirely distinct export pathways. Mol. Cell 2001, 8:397-406.
35. Culjkovic B., et al. eIF4E is a central node of an RNA regulon that governs cellular proliferation. J. Cell Biol. 2006, 175:415-426.
36. Topisirovic I., et al. Molecular dissection of the eukaryotic initiation factor 4E (eIF4E) export-competent RNP. EMBO J. 2009, 8:1087-1098.
37. Culjkovic B., Borden K.L. Understanding and targeting the eukaryotic translation initiation factor eIF4E in head and neck cancer. J. Oncol. 2009, 2009:981679.
38. Dominguez-Sanchez M.S., et al. Differential expression of THOC1 and ALY mRNP biogenesis/export factors in human cancers. BMC Cancer 2011, 11:77.
39. Yang J., et al. Relationships of hHpr1/p84/Thoc1 expression to clinicopathologic characteristics and prognosis in non-small cell lung cancer. Ann. Clin. Lab. Sci. 2008, 38:105-112.
40. Guo S., et al. Linking transcriptional elongation and messenger RNA export to metastatic breast cancers. Cancer Res. 2005, 65:3011-3016.
41. Saito Y., et al. ALY as a potential contributor to metastasis in human oral squamous cell carcinoma. J. Cancer Res. Clin. Oncol. 2013, 139:585-594.
42. Shen A., et al. Expression of CRM1 in human gliomas and its significance in p27 expression and clinical prognosis. Neurosurgery 2009, 65:153-159.
43. Huang W.Y., et al. Prognostic value of CRM1 in pancreas cancer. Clin. Invest. Med. 2009, 32:E315.
44. van der Watt P.J., et al. The Karyopherin proteins, Crm1 and Karyopherin beta1, are overexpressed in cervical cancer and are critical for cancer cell survival and proliferation. Int. J. Cancer 2009, 124:1829-1840.
45. Turner J.G., et al. Nuclear export of proteins and drug resistance in cancer. Biochem. Pharmacol. 2012, 83:1021-1032.
46. Fujimura S., et al. Increased expression of germinal center-associated nuclear protein RNA-primase is associated with lymphomagenesis. Cancer Res. 2005, 65:5925-5934.
47. Wickramasinghe V.O., et al. GANP enhances the efficiency of mRNA nuclear export in mammalian cells. Nucleus 2010, 1:393-396.
48. Okamoto N., et al. Germinal center-associated nuclear protein (GANP) is involved in mRNA export of Shugoshin-1 required for centromere cohesion and in sister-chromatid exchange. Genes Cells 2010, 15:471-484.
49. Xu S., Powers M.A. Nuclear pore proteins and cancer. Semin. Cell Dev. Biol. 2009, 20:620-630.
50. Martinez N., et al. The nuclear pore complex protein Nup88 is overexpressed in tumor cells. Cancer Res. 1999, 59:5408-5411.
51. Gould V.E., et al. A novel, nuclear pore-associated, widely distributed molecule overexpressed in oncogenesis and development. Am. J. Pathol. 2000, 157:1605-1613.
52. Emterling A., et al. Clinicopathological significance of Nup88 expression in patients with colorectal cancer. Oncology 2003, 64:361-369.
53. Boer J., et al. Overexpression of the nucleoporin CAN/NUP214 induces growth arrest, nucleocytoplasmic transport defects, and apoptosis. Mol. Cell. Biol. 1998, 18:1236-1247.
54. Chin K., et al. Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell 2006, 10:529-541.
55. Soman N.R., et al. The TPR-MET oncogenic rearrangement is present and expressed in human gastric carcinoma and precursor lesions. Proc. Natl. Acad. Sci. U.S.A. 1991, 88:4892-4896.
56. Yu J., et al. Frequency of TPR-MET rearrangement in patients with gastric carcinoma and in first-degree relatives. Cancer 2000, 88:1801-1806.
57. Pierotti M.A., Greco A. Oncogenic rearrangements of the NTRK1/NGF receptor. Cancer Lett. 2006, 232:90-98.
58. Ma Z., et al. Fusion of ALK to the Ran-binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor. Genes Chromosomes Cancer 2003, 37:98-105.
59. Culjkovic-Kraljacic B., et al. The oncogene eIF4E reprograms the nuclear pore complex to promote mRNA export and oncogenic transformation. Cell Rep. 2012, 2:207-215.
60. Lazaris-Karatzas A., et al. Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap. Nature 1990, 345:544-547.
61. Wendel H.G., et al. Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy. Nature 2004, 428:332-337.
62. Cohen N., et al. PML RING suppresses oncogenic transformation by reducing the affinity of eIF4E for mRNA. EMBO J. 2001, 20:4547-4559.
63. Topisirovic I., et al. Aberrant eukaryotic translation initiation factor 4E-dependent mRNA transport impedes hematopoietic differentiation and contributes to leukemogenesis. Mol. Cell. Biol. 2003, 23:8992-9002.
64. Faria P.A., et al. VSV disrupts the Rae1/mrnp41 mRNA nuclear export pathway. Mol. Cell 2005, 17:93-102.
65. Kodiha M., et al. Dissecting the signaling events that impact classical nuclear import and target nuclear transport factors. PLoS ONE 2009, 4:e8420.
66. Crampton N., et al. Oxidative stress inhibits nuclear protein export by multiple mechanisms that target FG nucleoporins and Crm1. Mol. Biol. Cell 2009, 20:5106-5116.
67. Chakraborty P., et al. Nucleoporin levels regulate cell cycle progression and phase-specific gene expression. Dev. Cell 2008, 15:657-667.
68. Farny N.G., et al. Definition of global and transcript-specific mRNA export pathways in metazoans. Genes Dev. 2008, 22:66-78.
69. Carmody S.R., et al. The mitogen-activated protein kinase Slt2 regulates nuclear retention of non-heat shock mRNAs during heat shock-induced stress. Mol. Cell. Biol. 2010, 30:5168-5179.
70. Rollenhagen C., et al. Following temperature stress, export of heat shock mRNA occurs efficiently in cells with mutations in genes normally important for mRNA export. Eukaryot. Cell 2007, 6:505-513.
71. Vainberg I.E., et al. Nuclear export of heat shock and non-heat-shock mRNA occurs via similar pathways. Mol. Cell. Biol. 2000, 20:3996-4005.
72. Katahira J., et al. Adaptor Aly and co-adaptor Thoc5 function in the Tap-p15-mediated nuclear export of HSP70 mRNA. EMBO J. 2009, 28:556-567.
73. Okada M., et al. Akt phosphorylation and nuclear phosphoinositide association mediate mRNA export and cell proliferation activities by ALY. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:8649-8654.
74. Feng Y., et al. Overexpression of the inositol phosphatase SopB in human 293 cells stimulates cellular chloride influx and inhibits nuclear mRNA export. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:875-879.
75. Culjkovic B., et al. The eIF4E RNA regulon promotes the Akt signaling pathway. J. Cell Biol. 2008, 181:51-63.
76. Chen Y.C., et al. Overexpression of NBS1 contributes to transformation through the activation of phosphatidylinositol 3-kinase/Akt. J. Biol. Chem. 2005, 280:32505-32511.
77. Azmi A.S., et al. Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin. Blood 2009, 114:257-260.
78. Assouline S., et al. Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-ofprinciple clinical trial with ribavirin. Blood 2009, 114:257-260.
79. Kraljacic B.C., et al. Inhibition of eIF4E with ribavirin cooperates with common chemotherapies in primary acute myeloid leukemia specimens. Leukemia 2011, 25:1197-1200.
80. Kentsis A., et al. Ribavirin suppresses eIF4E-mediated oncogenic transformation by physical mimicry of the 7-methyl guanosine mRNA cap. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:18105-18110.
81. Kentsis A., et al. Further evidence that ribavirin interacts with eIF4E. RNA 2005, 11:1762-1766.
82. Borden K.L., Culjkovic-Kraljacic B. Ribavirin as an anti-cancer therapy: acute myeloid leukemia and beyond?. Leuk. Lymphoma 2010, 51:1805-1815.
83. Rizzieri D.A., et al. A phase 2 clinical trial of deforolimus (AP23573, MK-8669), a novel mammalian target of rapamycin inhibitor, in patients with relapsed or refractory hematologic malignancies. Clin. Cancer Res. 2008, 14:2756-2762.
84. Graff J.R., Zimmer S.G. Translational control and metastatic progression: enhanced activity of the mRNA cap-binding protein eIF-4E selectively enhances translation of metastasis-related mRNAs. Clin. Exp. Metastasis 2003, 20:265-273.
85. Lei H., et al. Export and stability of naturally intronless mRNAs require specific coding region sequences and the TREX mRNA export complex. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:17985-17990.
86. Gruter P., et al. TAP, the human homolog of Mex67p, mediates CTE-dependent RNA export from the nucleus. Mol. Cell 1998, 1:649-659.
87. Yi R., et al. Recruitment of the Crm1 nuclear export factor is sufficient to induce cytoplasmic expression of incompletely spliced human immunodeficiency virus mRNAs. J. Virol. 2002, 76:2036-2042.
88. Ohno M., et al. PHAX, a mediator of U snRNA nuclear export whose activity is regulated by phosphorylation. Cell 2000, 101:187-198.
89. Leisegang M.S., et al. Exportin T and Exportin 5: tRNA and miRNA biogenesis - and beyond. Biol. Chem. 2012, 393:599-604.